• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Amarin Corporation plc (AMRN)

    1.51 Up 0.05(3.42%) 4:00PM EST
    |After Hours : 1.52 Up 0.01 (0.66%) 4:21PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Amarin Corporation plc
    2 Pembroke House
    Upper Pembroke Street 28-32
    Dublin, 2
    Ireland - Map
    Phone: 353 1 669 9020
    Website: http://www.amarincorp.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Other
    Full Time Employees:185

    Business Summary 

    Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Amarin Corporation plc

    Key Executives 
    Mr. John F. Thero , 54
    Chief Exec. Officer, Pres, Assistant Sec. and Director
    Mr. Joseph T. Kennedy J.D., 47
    Chief Compliance Officer, Sr. VP, Gen. Counsel and Sec.
    Dr. Steven B. Ketchum Ph.D., 50
    Sr. VP and Pres of R&D
    Mr. Michael James Farrell , 37
    Principal Financial Officer, Principal Accounting Officer and Controller
    Mr. Alan D. Cooke , 44
    Chief Operating Officer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders